Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.

Show other versions (1)

BACKGROUND: Recent evidence suggests that visit-to-visit variability in systolic blood pressure (SBP) and maximum SBP are predictors of cardiovascular disease. However, it remains uncertain whether these parameters predict the risks of macrovascular and microvascular complications in patients with t...

Full description

Bibliographic Details
Main Authors:	Hata, J, Arima, H, Rothwell, P, Woodward, M, Zoungas, S, Anderson, C, Patel, A, Neal, B, Glasziou, P, Hamet, P, Mancia, G, Poulter, N, Williams, B, Macmahon, S, Chalmers, J
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
by: Hata, J, et al.
Published: (2013)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
by: Hata, J, et al.
Published: (2012)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
by: Zoungas, S, et al.
Published: (2009)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
by: Mohammedi, K, et al.
Published: (2017)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
by: Patel, A, et al.
Published: (2007)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
by: Kamel Mohammedi, et al.
Published: (2017-07-01)

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.
by: Rothwell, P, et al.
Published: (2010)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by: Welsh, P, et al.
Published: (2018)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
by: Ohkuma, T, et al.
Published: (2017)

Systolic visit-to-visit blood pressure variability increases risk of myocardial infarction and congestive heart failure in patients given valsartan or amlodipine in the value trial
by: Mehlum, MH, et al.
Published: (2016)

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
by: Kengne, A, et al.
Published: (2009)

Selective Autophagy in Hyperglycemia-Induced Microvascular and Macrovascular Diseases
by: Leena P. Bharath, et al.
Published: (2021-08-01)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
by: Ohkuma, T, et al.
Published: (2018)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
by: Adler, A, et al.
Published: (2000)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
by: Anubhav Chauhan, et al.
Published: (2016-01-01)

Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study
by: Wang A, et al.
Published: (2016-08-01)

Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke.
by: Howard, S, et al.
Published: (2009)

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
by: C. R. L. Cardoso, et al.
Published: (2018-02-01)

Microvascular outcomes in type 2 diabetes - Authors' reply
by: Zoungas, S, et al.
Published: (2017)

Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria.
by: Hanson, J, et al.
Published: (2012)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
by: Perkovic, V, et al.
Published: (2013)

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
by: Turnbull, F, et al.
Published: (2009)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
by: Zoungas, S, et al.
Published: (2012)

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial
by: Michael Böhm, et al.
Published: (2016-02-01)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
by: Bijan Roshan, et al.
Published: (2010-12-01)

Lowering blood pressure reduces renal events in type 2 diabetes.
by: de Galan, B, et al.
Published: (2009)

Spatial and temporal VEGF receptor intracellular trafficking in microvascular and macrovascular endothelial cells
by: Juliete A. F. Silva, et al.
Published: (2021-08-01)

Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses
by: Afnan Mansour, et al.
Published: (2023-03-01)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
by: Zoungas, S, et al.
Published: (2017)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
by: Karunakaran, S, et al.
Published: (1996)

Lipoprotein Subclasses Independently Contribute to Subclinical Variance of Microvascular and Macrovascular Health
by: Lukas Streese, et al.
Published: (2022-07-01)

Relation Between Microvascular and Macrovascular Hemodynamics in Normal Epicardial Coronary Arteries
by: Pelin Özer, et al.
Published: (2021-10-01)

Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic
by: Al-Wakeel Jamal, et al.
Published: (2009-01-01)

Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications
by: Chandy Anila, et al.
Published: (2008-01-01)

12.2 HIGH PULSE WAVE VELOCITY IS ASSOCIATED WITH INCREASED VISIT-TO-VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY IN CONTROLLED ARTERIAL HYPERTENSION
by: Elena Troitskaya, et al.
Published: (2016-11-01)

China Stroke Primary Prevention Trial: Visit‐to‐Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients
by: Xi Men, et al.
Published: (2017-03-01)

Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial
by: Arima, H, et al.
Published: (2011)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
by: Blomster, J, et al.
Published: (2017)

Human Liver Endothelial Cells, But Not Macrovascular or Microvascular Endothelial Cells, Engraft in the Mouse Liver
by: Ebtisam El Filali, et al.
Published: (2013-10-01)